Relation Announces Collab with GSK on Fibrosis & Osteoarthritis
10 Dec 2024 //
GLOBENEWSWIRE
Relation Partners with GSK for Fibrotic Diseases & Osteoarthritis
10 Dec 2024 //
GLOBENEWSWIRE
GSK pair with Relation to develop fibrosis, arthritis therapies
10 Dec 2024 //
GLOBENEWSWIRE
Relation Therapeutics secures $35 million of new seed financing
14 Mar 2024 //
GLOBENEWSWIRE
Relation announces launch of flagship integrated wet–dry laboratory
22 Feb 2023 //
BUSINESSWIRE
Relation Therapeutics announces launch of flagship integrated wet–dry laboratory
21 Feb 2023 //
BUSINESSWIRE
Relation Therapeutics Names David Roblin as CEO and Lindsay Edwards as CTO
09 Jun 2022 //
BUSINESSWIRE